Neuromuscular Mechanisms of Specific Trunk Interventions in Children With CP

NCT ID: NCT05805410

Last Updated: 2025-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Determine the effect of repeated pelvis perturbation training on trunk posture and locomotor function in children with CP.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will determine whether repeat exposure to pelvis perturbation during sitting astride will induce functional improvements in trunk postural control and locomotion in children with CP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Child Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly assigned to two groups
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robotic hippotherapy

For the robotic training group, each subject will be trained for 40 minutes. Specifically, each participant will sit astride on a robotic horse with the force perturbation will be applied in the anterior-posterior direction and up/down direction.

Group Type EXPERIMENTAL

robotic hippotherapy

Intervention Type BEHAVIORAL

A custom designed cable-driven robotic system that mimics horseback movement during walking was used in this study.

Conventional physical therapy

For the conventional physical therapy group, each subject will be trained for 40 minutes, which will include 10 minutes of stretching, followed by 10 minutes of sitting and 10 minutes of standing balance training, and 10 minutes of treadmill walking.

Group Type ACTIVE_COMPARATOR

Conventional physical therapy

Intervention Type BEHAVIORAL

Stretching of trunk and leg muscles, followed by sitting and standing balance training, and conventional treadmill walking.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

robotic hippotherapy

A custom designed cable-driven robotic system that mimics horseback movement during walking was used in this study.

Intervention Type BEHAVIORAL

Conventional physical therapy

Stretching of trunk and leg muscles, followed by sitting and standing balance training, and conventional treadmill walking.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with a diagnosis of bilateral spastic CP attributed to complications of prematurity, intracranial hemorrhage and periventricular leukmalacia according to the definition of Bax.
* Children aged 4 to 12 years old without Botulinum toxin treatment within 6 months, and without surgeries (such as selective dorsal rhizotomy) within 12 months before the onset of the training.
* Subjects will be able to remain seated without help for ≥10s.
* GMFCS levels will be I to IV.
* Children must be able to signal pain, fear or discomfort reliably.
* Children with mild scoliosis (Cobb angle \< 20 °).
* Children with CP who have no prior hippotherapy experiences within 6 months.

Exclusion Criteria

* severe lower extremity contractures, fractures, osseous instabilities, osteoporosis.
* severe disproportional bone growth.
* unhealed skin lesions in the lower extremities.
* thromboembolic diseases, cardiovascular instability.
* aggressive or self-harming behaviors.
Minimum Eligible Age

4 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shirley Ryan AbilityLab

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ming Wu

Research Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ming Wu

Role: PRINCIPAL_INVESTIGATOR

Shirley Ryan AbilityLab

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shirley Ryan AbilityLab

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ming Wu

Role: CONTACT

3122380700

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ming Wu, PhD

Role: primary

3122380700

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01NS115487

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.